Magnetic Insight Company
Magnetic Insight (MI) introduced magnetic particle imaging into the preclinical diagnostic research market enabling quantitative cell tracking, imaging of vascular function, detecting metastatic tumors, visualizing inflammation, CAR-T cell therapies and initial research into regenerative medicine.
Magnetic Particle Imaging (MPI) is a new imaging modality that directly detects iron oxide nanoparticle tracers using time-varying magnetic fields. Because the tracer is not normally found in the body, MPI images have exceptional contrast and high sensitivity.
Magnetic Particle Imaging uses a unique geometry of magnetics to create a field free region (FFR). This is something you may have experienced when pointing two magnets at each other. That sensitive point controls the direction of a nanoparticle.
Magnetic Particle Imaging (MPI) is a new imaging modality that directly detects iron oxide nanoparticle tracers using time-varying magnetic fields. Because the tracer is not normally found in the body, MPI images have exceptional contrast and high sensitivity.
Magnetic Particle Imaging uses a unique geometry of magnetics to create a field free region (FFR). This is something you may have experienced when pointing two magnets at each other. That sensitive point controls the direction of a nanoparticle.
Investors
Technology:
MarketPlace
Industry:
P4 Medicine
Headquarters:
United States
Founded Date:
2014
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
9
Total Funding:
$25.6M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series A
Register and Claim Ownership